By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — The UK Centre for Medical Research and Innovation will maintain "a strong focus" on cancer, heart disease, and stroke as well as disorders of the immune system and later-life diseases of the nervous system, according to a scientific vision and research strategy outline made public by partners in the planned £600 million institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.